Researchers Find Possible Clues To Tamoxifen Resistance In Breast Cancer

Breast patients who become resistant to tamoxifen may have low levels of a called Rho GDI-alpha, according to a study published March 30 in the Journal of the National Institute. Women whose tumors have estrogen receptors (ERs) often take tamoxifen after to prevent recurrence of the and keep it from metastasizing to other parts of the body…


Read more

Related posts

Leave a Reply